Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CBA Pharma
AddedFeb 15, 2024
UpdatedJun 18, 2026
CBA Pharma

CBA Pharma

Public

CBA Pharma, Inc.: A leading drug manufacturer specializing in medical oncology.

HQ
Lexington, KY, US
Founded
1999
Overview
Compare
Fundraising
Employees
Website

CBA Pharma, Inc., founded in Lexington, Kentucky, is a leading pharmaceutical company specializing in the manufacturing of drugs for medical oncology. The company's core mission is to advance cancer treatment through innovative pharmaceutical solutions, aiming to improve patient outcomes and quality of life. CBA Pharma offers a range of oncology drugs designed to meet the needs of healthcare providers and patients, focusing on delivering high-quality, effective treatments in the oncology market.

Notable affiliated individuals and investors include key figures in the pharmaceutical and healthcare industries who have supported the company's growth and innovation. CBA Pharma has achieved significant milestones in drug development and manufacturing, contributing to advancements in cancer treatment. The company's impact is evident in its commitment to providing cutting-edge oncology medications, positioning itself as a vital player in the fight against cancer.

CBA Pharma - Similar Companies

Cahaba Pharmaceuticals logo

Cahaba Pharmaceuticals

MBC Pharma logo

MBC Pharma

mbcpharma.com

CNBX Pharmaceuticals logo

CNBX Pharmaceuticals

cnbxpharma.com

Abby Med logo

Abby Med

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

CASI Pharmaceuticals logo

CASI Pharmaceuticals

Onco360 Oncology Pharmacy logo

Onco360 Oncology Pharmacy

onco360.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Panacea Pharmaceuticals logo

Panacea Pharmaceuticals

Cullinan Oncology logo

Cullinan Oncology

PleoPharma logo

PleoPharma

pleopharma.com

NextCure logo

NextCure

nextcure.com

Akanocure Pharmaceuticals logo

Akanocure Pharmaceuticals

akanocure.com

Core Oncology logo

Core Oncology

CBA Pharma - Quick Facts

Who are CBA Pharma's competitors?

Companies similar to CBA Pharma include Cahaba Pharmaceuticals, MBC Pharma, CNBX Pharmaceuticals and Abby Med.

When was CBA Pharma founded?

CBA Pharma was founded in 1999.

Where is CBA Pharma's headquarters located?

CBA Pharma's headquarters is located in Lexington, KY, US.

When was CBA Pharma's last funding round?

CBA Pharma's most recent funding round was for $100k (USD) in January 2015.

How much has CBA Pharma raised to-date?

As of Jan 1, 2015, CBA Pharma has raised a total of $9.3M (USD).

How many employees does CBA Pharma have?

CBA Pharma has 30 employees as of Feb 5, 2024.

CBA Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Oncology Drugs
Tags
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified